Apolipoprotein A-IFin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene.
暂无分享,去创建一个
J. Viikari | L. Paulin | H. Gylling | T. Miettinen | K. Kontula | H. Miettinen | Helena Gylling | T. Miettinen | K. Kontula | Lars Paulin | J. Viikari
[1] A. von Eckardstein,et al. A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[2] P. Shah,et al. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. , 1994, Circulation.
[3] A. von Eckardstein,et al. A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. S. Ranu. Relief of DNA polymerase stop(s) due to severity of secondary structure of single-stranded DNA template during DNA sequencing. , 1994, Analytical biochemistry.
[5] Lawrence A Leiter,et al. Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia. , 1994, The Journal of clinical investigation.
[6] Hao Li,et al. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[7] K. Lackner,et al. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene. , 1993, The Journal of clinical investigation.
[8] T. Arinami,et al. Autosomal dominant hypoalphalipoproteinemia due to a completely defective apolipoprotein A-I gene. , 1993, Biochemical and biophysical research communications.
[9] J. Lee,et al. Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation. Structure:function relationships. , 1993, Journal of Biological Chemistry.
[10] A. Tall,et al. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. , 1993, The Journal of clinical investigation.
[11] D. Rader,et al. Familial HDL deficiency due to marked hypercatabolism of normal apoA-I. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[12] I. Goldberg,et al. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. , 1993, The Journal of clinical investigation.
[13] G. Assmann,et al. High Density Lipoproteins, Reverse Transport of Cholesterol, and Coronary Artery Disease Insights From Mutations , 1993, Circulation.
[14] G. Franceschini,et al. In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia. , 1993, The Journal of clinical investigation.
[15] W. J. Johnson,et al. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. , 1992, Journal of lipid research.
[16] S. Grundy,et al. Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. , 1992, Journal of lipid research.
[17] C. Fielding,et al. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding. , 1992, The Journal of biological chemistry.
[18] P. Hawkins,et al. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[19] Hinrich Abken,et al. A procedure to standardize CAT reporter gene assay , 1992, Nucleic Acids Res..
[20] H. Gylling,et al. Non-cholesterol sterols, absorption and synthesis of cholesterol and apolipoprotein A-I kinetics in a Finnish lecithin-cholesterol acyltransferase deficient family. , 1992, Atherosclerosis.
[21] N. Seidah,et al. Proprotein and prohormone convertases of the subtilisin family Recent developments and future perspectives , 1992, Trends in Endocrinology & Metabolism.
[22] D. Rader,et al. In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. , 1992, Journal of lipid research.
[23] R. Krauss,et al. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.
[24] S. Deeb,et al. A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins. , 1991, The Journal of biological chemistry.
[25] A. Tall,et al. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. , 1991, The Journal of biological chemistry.
[26] S. Grundy,et al. Evaluation of a method for study of kinetics of autologous apolipoprotein A-I. , 1991, Journal of lipid research.
[27] K. Yamakawa,et al. Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Yokoyama,et al. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.
[29] S. Eisenberg,et al. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. , 1991, The Journal of clinical investigation.
[30] M. Uhlén,et al. Bidirectional solid-phase sequencing of in vitro-amplified plasmid DNA. , 1991, BioTechniques.
[31] A. von Eckardstein,et al. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. , 1991, Journal of lipid research.
[32] R. Gregg,et al. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. , 1990, Genomics.
[33] A. von Eckardstein,et al. Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure. , 1990, The Journal of biological chemistry.
[34] A. von Eckardstein,et al. Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I. , 1989, The Journal of clinical investigation.
[35] D. Gordon,et al. High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.
[36] J. Ordovás,et al. Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. , 1989, The Journal of biological chemistry.
[37] S. Ho,et al. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.
[38] Charles R.scriver,et al. The Metabolic basis of inherited disease , 1989 .
[39] E. Ferris,et al. DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Dobiášová,et al. Cold labelled substrate and estimation of cholesterol esterification rate in lecithin cholesterol acyltransferase radioassay. , 1986, Physiologia Bohemoslovaca.
[41] E. Bosisio,et al. Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns. , 1985, Atherosclerosis.
[42] S. Karathanasis. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[43] G. Utermann,et al. Apolipoprotein A‐IGiessen (Pro143→Arg) , 1984 .
[44] E. Schaefer. Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency. , 1984, Arteriosclerosis.
[45] R. Mahley,et al. Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 type. , 1984, The Journal of biological chemistry.
[46] A. Kornblihtt,et al. Gene structure of human apolipoprotein A1. , 1983, Nucleic acids research.
[47] R. Mahley,et al. Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. , 1983, The Journal of biological chemistry.
[48] G. Assmann,et al. Papers and Notes on I I Methodology One-step Screening Method for the Polymorphism of Apolipoproteins A-i, A-11, and A-iv , 2022 .
[49] W. Rutter,et al. Polymorphic DNA region adjacent to the 5' end of the human insulin gene. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[50] R. Mahley,et al. A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. , 1980, The Journal of clinical investigation.
[51] R. Mahley,et al. DECREASED HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVELS WITH SIGNIFICANT LIPOPROTEIN MODIFICATIONS AND WITHOUT CLINICAL ATHEROSCLEROSIS IN AN ITALIAN FAMILY , 1980 .
[52] C. Blum,et al. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. , 1978, The New England journal of medicine.
[53] W. Fitch. Phylogenies constrained by the crossover process as illustrated by human hemoglobins and a thirteen-cycle, eleven-amino-acid repeat in human apolipoprotein A-I. , 1977, Genetics.
[54] A. Mclachlan,et al. Repeated helical pattern in apolipoprotein-A-I , 1977, Nature.
[55] E. Southern. Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.
[56] U. Schibler,et al. Changes in size and secondary structure of the ribosomal transcription unit during vertebrate evolution. , 1975, Journal of molecular biology.
[57] A. Gotto,et al. A molecular theory of lipid—protein interactions in the plasma lipoproteins , 1974, FEBS letters.
[58] D. Bilheimer,et al. The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins. , 1972, Biochimica et biophysica acta.
[59] C. Fielding,et al. A protein cofactor of lecithin:cholesterol acyltransferase. , 1972, Biochemical and biophysical research communications.
[60] D. Bilheimer,et al. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.
[61] J. Glomset,et al. The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.
[62] A. Mcfarlane,et al. Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.
[63] C. Matthews,et al. The theory of tracer experiments with 131I-labelled plasma proteins. , 1957, Physics in medicine and biology.